Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44394 clinical trials with a EudraCT protocol, of which 7406 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,394)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

44,394 result(s) found. Displaying page 1,881 of 2,220.

EudraCT Number: 2020-000569-18	Sponsor Protocol Number: RECHMPL20_0094	Start Date*: 2020-10-02
Sponsor Name:University Hospital of Montpellier
Full Title: NEOADUVANT ATEZOLIZUMAB AND ADJUVANT ATEZOLIZUMAB + BEVACIZUMAB IN COMBINATION WITH PERCUTANEOUS RADIOFREQUENCY ABLATION OF SMALL HCC: A MULTICENTER RANDOMIZED PHASE II TRIAL
Medical condition: Digestive oncology
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: FR (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2020-003323-42

Sponsor Protocol Number: 29BRC20.0203

Start Date*: 2021-03-01

Sponsor Name:CHRU de Brest

Full Title: Diagnostic Performance of prostate specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) imaging for Pre-operative lymph Node assessment in intermediate and hig...

Medical condition: Prostate cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.0	100000004864	10036946	Prostatic cancer	LLT

Population Age: Adults, Elderly

Gender: Male

Trial protocol: FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2018-000367-83

Sponsor Protocol Number: ENGOT-Cx10/GEICO68-C/BEATcc

Start Date*: 2018-08-08

Sponsor Name:Grupo Español de Investigación en Cáncer de Ovario (GEICO)

Full Title: A Randomized Phase III Trial of Platinum Chemotherapy plus Paclitaxel with Bevacizumab and Atezolizumab versus Platinum Chemotherapy plus Paclitaxel and Bevacizumab in Metastatic (stage IVB), Persi...

Medical condition: Metastatic (stage IVB), Persistent, or Recurrent Carcinoma of the Cervix

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10008342	Cervix carcinoma	PT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: ES (Ongoing) FR (Trial now transitioned) NO (Trial now transitioned) SE (Trial now transitioned) DE (Trial now transitioned) IT (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2017-002490-19

Sponsor Protocol Number: UKER-FECD-RIPA-01

Start Date*: 2017-12-07

Sponsor Name:Universitätsklinikum Erlangen

Full Title: Prospective single-centre randomized observer-blind placebo-controlled parallel-group phase IIa clinical trial to investigate the safety and efficacy of ripasudil 0.4% eye drops after descemetorhex...

Medical condition: Moderate to advanced Fuchs endothalial corneal dystrophy (FECD)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.1	100000004850	10062973	Fuchs' endothelial dystrophy	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2021-005627-21	Sponsor Protocol Number: APHP211043	Start Date*: 2022-08-31
Sponsor Name:APHP
Full Title: 3-day intravenous antibiotic treatment versus 3-day intravenous followed by 7-day oral antibiotic treatment for acute pyelonephritis in children 1 month to 3 years old: a non-inferiority open rando...
Medical condition: Acute pyelonephritis in children 1 month to 3 years old
Disease:
Population Age: Infants and toddlers, Children, Under 18		Gender: Male, Female
Trial protocol: FR (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2019-004740-30

Sponsor Protocol Number: PHRCN2018

Start Date*: 2021-09-15

Sponsor Name:Centre Hospitalier Le Vinatier

Full Title: Cannabidiol for reducing drinking in alcohol use disorder and modifying the effects of alcohol on the brain and the liver: a phase 2 clinical trial.

Medical condition: CARAMEL is an exploratory phase-2 study conducted in subjects with AUD (alcohol use disorder) and current heavy drinking level, aiming to confirm the different properties of CBD observed in animal ...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	100000004873	10001590	Alcohol addiction	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2019-002327-15	Sponsor Protocol Number: APHP180596	Start Date*: 2023-03-15
Sponsor Name:APHP
Full Title: Beta-lactam Intermittent versus Continuous infusion and Combination antibiotic therapy in Sepsis
Medical condition: Beta-lactam Intermittent vs Continuous infusion and Combination antibiotic therapy in Sepsis
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: FR (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2018-003801-24

Sponsor Protocol Number: P160925J

Start Date*: 2019-11-06

Sponsor Name:Assistance Publique - Hôpitaux de Paris

Full Title: A multicenter, prospective, randomized, placebo-controlled, double-blind, multi-arm, multi-stage clinical trial of Ivabradine for heart Rate control In Septic shock

Medical condition: Trial subjects are adult patients with septic shock.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10021881 - Infections and infestations	10040070	Septic shock	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2013-001525-10	Sponsor Protocol Number: bins1	Start Date*: 2013-07-30
Sponsor Name:Erasmus MC
Full Title: Studying the metabolism of sorafenib (Nexavar®) by OATP1B blockage in adult cancer patients
Medical condition: Cancer
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Completed)
Trial results: (No results available)

EudraCT Number: 2017-002559-27	Sponsor Protocol Number: 2017-03	Start Date*: 2018-03-29
Sponsor Name:Zaans Medisch Centrum
Full Title: ED50 and ED90 of intrathecal 1% chloroprocaine in day-case knee arthroscopy
Medical condition: Patients scheduled for ambulatory knee arthroscopy surgery receive intrathecal chloroprocaine
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Completed)
Trial results: (No results available)

EudraCT Number: 2021-004016-26	Sponsor Protocol Number: Clin_COVID-19_Corok	Start Date*: 2021-10-18
Sponsor Name:Meilahti Vaccine Research Center - Helsinki University Hospital
Full Title: Substudy "Responses to Covid-19 vaccines" in research "Clinical picture, immunology, genetics and pathogenesis of COVID-19 infection"
Medical condition: None
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: FI (Completed)
Trial results: (No results available)

EudraCT Number: 2010-023313-57	Sponsor Protocol Number: INF	Start Date*: 2012-04-10
Sponsor Name:Helsinki University Central Hospital
Full Title: Homing potential of the antigen specific B cell and antibody mediated immune response after vaccination
Medical condition: Basic healthy volunteers
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: FI (Completed)
Trial results: (No results available)

EudraCT Number: 2012-003058-10

Sponsor Protocol Number: IBCSG_42-12/BIG_2-12

Start Date*: 2013-04-03

Sponsor Name:International Breast Cancer Study Group (IBCSG)

Full Title: A randomized phase II study evaluating different schedules of nab-Paclitaxel in metastatic breast cancer

Medical condition: Patients with histologically or cytologically confirmed HER2-negative metastatic (stage IV) breast cancer who have not received chemotherapy for metastatic breast cancer.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	17.1	100000004864	10027475	Metastatic breast cancer	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: BE (Completed) SI (Completed) IE (Completed) IT (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2012-003484-22	Sponsor Protocol Number: PNC+AHEP	Start Date*: 2012-09-11
Sponsor Name:Helsinki University Central Hospital
Full Title: Immune response to pneumococcal conjugate vaccine in adults receiving hepatitis A vaccine concomitantly
Medical condition: 18 years old or older volunteers with general good health
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: FI (Completed) SE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2014-003474-16	Sponsor Protocol Number: Dukoral+Vivotif	Start Date*: 2015-08-26
Sponsor Name:Helsinki University Hospital
Full Title: Immunity elicited by concomitant administration of oral typhoid fever (Vivotif®) and cholera (Dukoral®) vaccines
Medical condition: Healthy volunteers
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: FI (Completed)
Trial results: (No results available)

EudraCT Number: 2012-004313-13

Sponsor Protocol Number: 20121001

Start Date*: 2013-01-22

Sponsor Name:Skåne University Hospital, Dept of Oncology

Full Title: A prospective study of the use of 68Ga-DOTA-TATE PET/CT in patients with neuroendocrine tumors.

Medical condition: Patients with neuroendocrine tumors, who are going to be diagnosed/evaluated with 68Ga-DOTA-TATE PET/CT instead of standard Octreoscan

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	100000004864	10062476	Neuroendocrine tumor	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed)

Trial results: (No results available)

EudraCT Number: 2021-002290-25	Sponsor Protocol Number: FEBATRIC	Start Date*: 2022-02-10
Sponsor Name:Nadační fond Donatio intensivistam
Full Title: Faecal bacteriotherapy for postantibiotic diarrhoea in critically ill patients
Medical condition: Postantibiotic diarrhoea
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: CZ (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2020-002862-15	Sponsor Protocol Number: BupivacTons20	Start Date*: 2021-03-03
Sponsor Name:Nordland Hospital. Bodø. Dep of Surgery
Full Title: Can topical anaesthesia with bupivacaine reduce pain after tonsillectomy?
Medical condition: Local pain after tonsillectomy, both at rest and during swallowing. Assessed by self-reporting at 1, 2, 3, 4, 5, 6 hours and 1,2,4 and 6 days after surgery.
Disease:
Population Age: Children, Adolescents, Under 18, Adults, Elderly		Gender: Male, Female
Trial protocol: NO (Completed)
Trial results: (No results available)

EudraCT Number: 2016-004163-39

Sponsor Protocol Number: OV126b

Start Date*: 2017-06-30

Sponsor Name:ARCAGY-GINECO

Full Title: A randomized, open-label, multicentric phase II trial of PEMBROLIZUMAB (Ketruda®) with chemotherapy versus chemotherapy alone (standard of care) as neo adjuvant treatment of ovarian cancer not amen...

Medical condition: advanced ovarian cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10070908	Ovarian cancer stage IV	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10070907	Ovarian cancer stage III	PT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: FR (Completed)

Trial results: View results

EudraCT Number: 2016-004381-25

Sponsor Protocol Number: 1608170

Start Date*: 2017-11-24

Sponsor Name:CHU de Saint-Etienne

Full Title: Study of the impact of a targeted decolonization of S. aureus in persistent carriers on the occurrence of S. aureus infections in hemodialysis patients

Medical condition: Hemodialysis patients

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000022103	10066622	Chronic hemodialysis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed)

Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Thu May 07 17:40:42 CEST 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA